Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flemming Bendtsen

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Experimental and Molecular Pathology|July 8, 2017
NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8<sup>+</sup> T cell migrationKasper Vadstrup, Elisabeth Douglas Galsgaard, Helle Jensen, et al.
Hepatology Communications|December 5, 2023
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trialThit M Kronborg, Robert Schierwagen, Kajetan Trošt, et al.
Journal of Crohn'S & Colitis|December 19, 2024
Clinical Outcomes After First-Line Anti- Tumor-Necrosis-Factor Treatment of Patients With Inflammatory Bowel Disease-A Prospective Multicenter Cohort StudyMirabella Zhao, Lone Larsen, Anders Dige, et al.
Scientific Reports|April 28, 2026
Magnetic resonance imaging-derived extracellular volume fraction mapping in metabolic dysfunction-associated steatotic liver disease reveals subclinical cardiac remodellingPuria Nabilou, Signe Wiese, Liv E Hetland, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 28, 2017
Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosisTroels M Busk, Flemming Bendtsen, Jørgen H Poulsen, et al.
Hepatology Communications|February 7, 2018
Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosisMichael Praktiknjo, Jennifer Lehmann, Mette J Nielsen, et al.
The Journal of Infectious Diseases|May 18, 2020
Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver StudyDitte Marie Kirkegaard-Klitbo, Andreas Fuchs, Stefan Stender, et al.
Crohn'S & Colitis 360|February 13, 2023
The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020Mads Damsgaard Wewer, Laura Arp, Melek Sarikaya, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
AIDS (London, England)|August 20, 2014
Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markersDiana J Leeming, Evrim Anadol, Robert Schierwagen, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Experimental and Molecular Pathology|July 8, 2017
NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8<sup>+</sup> T cell migrationKasper Vadstrup, Elisabeth Douglas Galsgaard, Helle Jensen, et al.
Hepatology Communications|December 5, 2023
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trialThit M Kronborg, Robert Schierwagen, Kajetan Trošt, et al.
Journal of Crohn'S & Colitis|December 19, 2024
Clinical Outcomes After First-Line Anti- Tumor-Necrosis-Factor Treatment of Patients With Inflammatory Bowel Disease-A Prospective Multicenter Cohort StudyMirabella Zhao, Lone Larsen, Anders Dige, et al.
Scientific Reports|April 28, 2026
Magnetic resonance imaging-derived extracellular volume fraction mapping in metabolic dysfunction-associated steatotic liver disease reveals subclinical cardiac remodellingPuria Nabilou, Signe Wiese, Liv E Hetland, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 28, 2017
Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosisTroels M Busk, Flemming Bendtsen, Jørgen H Poulsen, et al.
Hepatology Communications|February 7, 2018
Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosisMichael Praktiknjo, Jennifer Lehmann, Mette J Nielsen, et al.
The Journal of Infectious Diseases|May 18, 2020
Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver StudyDitte Marie Kirkegaard-Klitbo, Andreas Fuchs, Stefan Stender, et al.
Crohn'S & Colitis 360|February 13, 2023
The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020Mads Damsgaard Wewer, Laura Arp, Melek Sarikaya, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
AIDS (London, England)|August 20, 2014
Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markersDiana J Leeming, Evrim Anadol, Robert Schierwagen, et al.
Pageof 26